These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20856136)

  • 1. A proposed, evidence-based approach to the treatment of chronic Hepatitis B.
    Han SH; Durazo FA; Saab S; Tong MJ
    J Clin Gastroenterol; 2011 Mar; 45(3):259-66. PubMed ID: 20856136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy for chronic hepatitis B.
    Jafri SM; Lok AS
    Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
    Tong MJ; Hsien C; Hsu L; Sun HE; Blatt LM
    Hepatology; 2008 Oct; 48(4):1070-8. PubMed ID: 18688879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
    Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halting the natural history of hepatitis B viral infection: a paradigm shift.
    Perrillo RP; Jacobson IM
    Semin Liver Dis; 2007 Aug; 27 Suppl 1():3-8. PubMed ID: 17701844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
    Khokhar A; Afdhal NH
    Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical implications of hepatitis B virus genotype: Recent advances.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():123-30. PubMed ID: 21199523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B.
    Bekku D; Arai M; Imazeki F; Yonemitsu Y; Kanda T; Fujiwara K; Fukai K; Sato K; Itoga S; Nomura F; Yokosuka O
    J Gastroenterol Hepatol; 2011 Jan; 26(1):122-8. PubMed ID: 21175805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
    Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
    Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.
    Brown A; Goodman Z
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):187-98. PubMed ID: 22375524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
    J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update.
    Tong MJ; Hsu L; Chang PW; Blatt LM
    J Gastroenterol Hepatol; 2011 May; 26(5):829-35. PubMed ID: 21214888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V; Craxì A
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF; Lai CL
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence variation of hepatitis B virus precore-core open reading frame isolated from serum and liver of children with chronic hepatitis B before and after interferon treatment.
    Cabrerizo M; Bartolomé J; Otero M; Ruiz-Moreno M; Carreño V
    J Med Virol; 1999 Jul; 58(3):208-14. PubMed ID: 10447414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to overcome antiviral-resistant hepatitis B virus?
    Song BC
    Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.
    Moskovitz DN; Osiowy C; Giles E; Tomlinson G; Heathcote EJ
    J Viral Hepat; 2005 Jul; 12(4):398-404. PubMed ID: 15985011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.